For years, healthcare organizations appointed Chief Growth Officers with a relatively clear brief: drive revenue, expand market share, build commercial teams, and accelerate growth. Many of these executives emerged from traditional business development and sales leadership backgrounds, bringing deep expertise in market expansion, relationship development, and commercial execution.
Today, however, the growth agenda looks very different.
Technology, artificial intelligence (AI), consumerism, personalized medicine, wellness, and data-driven care models are reshaping how healthcare organizations compete and create value. As growth becomes more dependent on technology, analytics, strategic partnerships, and consumer engagement, healthcare organizations are rethinking the capabilities they need in their growth leaders. The goal is not simply to generate more growth, but to pursue growth that is scalable, economically sustainable, and capable of creating long-term value.
The result is a significant broadening of the Chief Growth Officer profile itself.
The Growth Mandate Is Expanding
For much of the past decade, growth leadership in healthcare followed a familiar playbook. Organizations expanded service lines, deepened referral relationships, opened new locations, built larger commercial teams, pursued acquisitions, and captured market share. These strategies created substantial value and helped build many of today's leading healthcare organizations.
While these strategies remain relevant, they are increasingly difficult to sustain as standalone drivers of growth. Referral-driven growth is more competitive, labor-intensive growth models are more expensive, and consumer expectations continue to evolve rapidly. Meanwhile, data has become a strategic asset, and AI is beginning to transform how healthcare organizations identify opportunities, engage patients, personalize experiences, and improve outcomes.
Against this backdrop, healthcare leaders and boards are placing greater emphasis on growth strategies that do more than drive revenue. They seek approaches that improve efficiency, strengthen margins, create durable competitive advantages, and translate growth into long-term enterprise value.
The precise mandate varies across healthcare services companies, physician and ambulatory platforms, technology-enabled businesses, and private equity-backed organizations. Across these models, however, the imperative remains the same: deliver durable, capital-efficient expansion.
Growth remains as important as ever. What is changing is the set of capabilities required to generate it.
That shift is already visible in the role itself. In many organizations, Chief Growth Officers now oversee areas beyond traditional business development, including digital channels, ecosystem partnerships, and novel business models. Depending on the organization, the role may also cover value-based growth, market expansion, or the integration of growth initiatives across acquired businesses.
Historically, many healthcare Chief Growth Officers advanced from frontline commercial roles into progressively larger sales leadership positions before ultimately assuming responsibility for enterprise growth. These leaders built successful careers on their ability to drive revenue, expand market presence, build high-performing teams, and execute disciplined commercial strategies.
Those skills remain foundational. However, today's environment requires more.
This broader remit requires growth leaders to understand not only how to drive demand, but also how to leverage technology, identify new business models, build strategic partnerships, and align commercial strategy with operational execution.
The most sought-after Chief Growth Officers are not simply commercial executives. They are enterprise builders capable of translating market disruption into sustainable competitive advantage. They must be able both to expand established growth channels and to create new ones.
The Rise of the Growth Architect
The next generation of Chief Growth Officers will do far more than oversee commercial performance. They will serve as architects of growth, designing and orchestrating the capabilities needed to generate sustainable value across an interconnected healthcare landscape.
These leaders integrate commercial strategy with clinical operations, consumer experience, and digital infrastructure. They leverage data to inform decisions, technology to enhance experiences, and partnerships to unlock new sources of value. Most importantly, they help organizations anticipate where healthcare is heading rather than merely reacting to market shifts as they occur.
In practice, this may mean integrating consumer access and digital acquisition, developing technology-enabled service lines, building new payer, employer, or channel partnerships, identifying opportunities for geographic or adjacent-market expansion, or using data to improve both the pace and economics of growth. In private equity-backed environments, it may also mean building a growth model that can be replicated across acquired businesses, accelerating both integration and value creation.
This evolution is already changing where organizations source talent. While some future Chief Growth Officers will continue to emerge from traditional sales and business development backgrounds, many will come from strategy, consulting, healthcare technology, product leadership, consumer businesses, innovation, and general management roles. Functional origin matters less than a demonstrated ability to connect disparate parts of an organization around a common growth agenda.
Success in this role will depend on five critical capabilities:
- Strategic foresight. The ability to identify emerging trends and position the organization ahead of market shifts, with a track record of recognizing and acting on opportunities before they become obvious.
- Ecosystem thinking. The ability to understand how providers, payers, consumers, technology platforms, and new care models interact, and to create value beyond the organization's traditional boundaries.
- Cross-functional leadership. The ability to align operations, finance, technology, clinical leadership, product, and commercial teams around a shared growth strategy and translate that strategy into coordinated execution.
- Technology and data fluency. The ability to use technology, analytics, and AI to identify opportunities, improve commercial effectiveness, enhance the consumer experience, and make growth more scalable. Applications may range from consumer segmentation and retention prediction to personalized care navigation, pricing optimization, and identifying new market or service-line opportunities.
- Value creation orientation. The discipline to pursue growth that strengthens competitive positioning and enterprise value, with a clear understanding of margin, capital requirements, scalability, and return on investment.
What Boards and CEOs Should Look for
The most forward-thinking boards, CEOs, and leadership teams are asking more expansive questions when evaluating growth leaders. The question is not just: Can this executive grow revenue?
Instead, they are asking:
- Can this leader identify and scale new growth channels?
- Can they leverage technology, analytics, and AI to improve the economics of growth?
- Can they build strategic partnerships and business models outside traditional healthcare channels?
- Can they balance organic growth with acquisition-led expansion and translate an investment thesis into execution?
- Can they build a repeatable growth engine that scales across markets, service lines, or portfolio businesses?
- Can they position the organization for where healthcare is going rather than where it has been?
The winning candidate is not necessarily the executive who managed the largest sales organization. It is the executive who can engineer a repeatable, resilient growth model for today's complex healthcare market.
Recruiting a broader leadership profile, however, is only part of the equation. Organizations must also give the Chief Growth Officer a mandate, reporting relationship, resources, and decision rights that match their expectations. A leader cannot deliver against an enterprise-wide mandate if the authority to shape strategy, technology, partnerships, consumer experience, and commercial execution remains fragmented or contested.
Ultimately, the real challenge is not access to talent. It is recognizing which leadership archetype will create advantage in the next era of healthcare.
Organizations that answer that question well will be better positioned to capture opportunities across technology-enabled services, consumer health, value-based care, longevity, digital health, and AI-enabled business models. But growth alone is not the objective. For for-profit and private equity-backed healthcare organizations in particular, it must translate into disciplined, measurable value.
The strongest Chief Growth Officers will know how to pursue that value without outpacing operational capacity, eroding margins, or building initiatives that cannot be replicated consistently across markets or businesses. They will connect technology, data, consumer insight, and operational execution around a common enterprise agenda.
The question is no longer who can execute the growth playbook of the past. It is who can design and scale the growth model their organization will need next.
